Germline BRCA1 variants are often associated with young-onset life-limiting grade 3 triple-negative breast cancers [24], whereas for women ≥60 years with no previous cancer history who develop an epithelial ovarian cancer, BRCA2 variants are more frequently detected [25]. The gene discussed is BRCA2; the disease is ovarian carcinoma.